750 related articles for article (PubMed ID: 17129656)
1. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
2. Characterization of asymmetric fluorogenic phosphonates as probes for developing organophosphorus hydrolases with broader stereoselectivity.
Amitai G; Adani R; Limanovich O; Teitlboim S; Yishay S; Tveria L; Yacov G; Meshulam H; Raveh L
Chem Biol Interact; 2008 Sep; 175(1-3):249-54. PubMed ID: 18588863
[TBL] [Abstract][Full Text] [Related]
3. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
[TBL] [Abstract][Full Text] [Related]
4. Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase (PON1) catalytic scavengers.
Ashani Y; Gupta RD; Goldsmith M; Silman I; Sussman JL; Tawfik DS; Leader H
Chem Biol Interact; 2010 Sep; 187(1-3):362-9. PubMed ID: 20303930
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory potency against human acetylcholinesterase and enzymatic hydrolysis of fluorogenic nerve agent mimics by human paraoxonase 1 and squid diisopropyl fluorophosphatase.
Blum MM; Timperley CM; Williams GR; Thiermann H; Worek F
Biochemistry; 2008 May; 47(18):5216-24. PubMed ID: 18396898
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
7. Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase.
Yeung DT; Smith JR; Sweeney RE; Lenz DE; Cerasoli DM
FEBS J; 2007 Mar; 274(5):1183-91. PubMed ID: 17286579
[TBL] [Abstract][Full Text] [Related]
8. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
9. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
[TBL] [Abstract][Full Text] [Related]
10. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
[TBL] [Abstract][Full Text] [Related]
11. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
12. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
[TBL] [Abstract][Full Text] [Related]
13. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
14. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
15. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
Luo C; Saxena A; Smith M; Garcia G; Radić Z; Taylor P; Doctor BP
Biochemistry; 1999 Aug; 38(31):9937-47. PubMed ID: 10433700
[TBL] [Abstract][Full Text] [Related]
16. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
17. Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase.
Millard CB; Lockridge O; Broomfield CA
Biochemistry; 1998 Jan; 37(1):237-47. PubMed ID: 9425044
[TBL] [Abstract][Full Text] [Related]
18. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochemistry; 2004 Mar; 43(11):3222-9. PubMed ID: 15023072
[TBL] [Abstract][Full Text] [Related]
19. A fluorogenic substrate for detection of organophosphatase activity.
Soukharev S; Hammond DJ
Anal Biochem; 2004 Apr; 327(1):140-8. PubMed ID: 15033522
[TBL] [Abstract][Full Text] [Related]
20. Effect of organophosphorus hydrolysing enzymes on obidoxime-induced reactivation of organophosphate-inhibited human acetylcholinesterase.
Herkenhoff S; Szinicz L; Rastogi VK; Cheng TC; DeFrank JJ; Worek F
Arch Toxicol; 2004 Jun; 78(6):338-43. PubMed ID: 14985944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]